BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36328355)

  • 1. A synthetic KLHL20 ligand to validate CUL3
    Farrell BM; Gerth F; Yang CR; Yeh JT
    Genes Dev; 2022 Sep; 36(17-18):1031-1042. PubMed ID: 36328355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
    Ishida T; Ciulli A
    SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the ligand spaces for E3 ligases for the design of protein degraders.
    Shah Zaib Saleem R; Schwalm MP; Knapp S
    Bioorg Med Chem; 2024 May; 105():117718. PubMed ID: 38621319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of E3 Ligase Ligands for Target Protein Degradation.
    Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses.
    Lee YR; Yuan WC; Ho HC; Chen CH; Shih HM; Chen RH
    EMBO J; 2010 May; 29(10):1748-61. PubMed ID: 20389280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders.
    Setia N; Almuqdadi HTA; Abid M
    Eur J Med Chem; 2024 Feb; 265():116041. PubMed ID: 38199162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
    Schröder M; Renatus M; Liang X; Meili F; Zoller T; Ferrand S; Gauter F; Li X; Sigoillot F; Gleim S; Stachyra TM; Thomas JR; Begue D; Khoshouei M; Lefeuvre P; Andraos-Rey R; Chung B; Ma R; Pinch B; Hofmann A; Schirle M; Schmiedeberg N; Imbach P; Gorses D; Calkins K; Bauer-Probst B; Maschlej M; Niederst M; Maher R; Henault M; Alford J; Ahrne E; Tordella L; Hollingworth G; Thomä NH; Vulpetti A; Radimerski T; Holzer P; Carbonneau S; Thoma CR
    Nat Commun; 2024 Jan; 15(1):275. PubMed ID: 38177131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
    Belcher BP; Ward CC; Nomura DK
    Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs.
    Girardini M; Maniaci C; Hughes SJ; Testa A; Ciulli A
    Bioorg Med Chem; 2019 Jun; 27(12):2466-2479. PubMed ID: 30826187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the target scope of KEAP1 E3 ligase-based PROTACs.
    Du G; Jiang J; Henning NJ; Safaee N; Koide E; Nowak RP; Donovan KA; Yoon H; You I; Yue H; Eleuteri NA; He Z; Li Z; Huang HT; Che J; Nabet B; Zhang T; Fischer ES; Gray NS
    Cell Chem Biol; 2022 Oct; 29(10):1470-1481.e31. PubMed ID: 36070758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, β-catenin, and FoxP3.
    Röth S; Kocaturk NM; Sathyamurthi PS; Carton B; Watt M; Macartney TJ; Chan KH; Isidro-Llobet A; Konopacka A; Queisser MA; Sapkota GP
    Cell Chem Biol; 2023 Oct; 30(10):1261-1276.e7. PubMed ID: 37591251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy.
    Fu SJ; Hu MC; Peng YJ; Fang HY; Hsiao CT; Chen TY; Jeng CJ; Tang CY
    Cells; 2020 May; 9(6):. PubMed ID: 32466489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis for Recruitment of DAPK1 to the KLHL20 E3 Ligase.
    Chen Z; Picaud S; Filippakopoulos P; D'Angiolella V; Bullock AN
    Structure; 2019 Sep; 27(9):1395-1404.e4. PubMed ID: 31279627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins.
    Shirasaki R; Matthews GM; Gandolfi S; de Matos Simoes R; Buckley DL; Raja Vora J; Sievers QL; Brüggenthies JB; Dashevsky O; Poarch H; Tang H; Bariteau MA; Sheffer M; Hu Y; Downey-Kopyscinski SL; Hengeveld PJ; Glassner BJ; Dhimolea E; Ott CJ; Zhang T; Kwiatkowski NP; Laubach JP; Schlossman RL; Richardson PG; Culhane AC; Groen RWJ; Fischer ES; Vazquez F; Tsherniak A; Hahn WC; Levy J; Auclair D; Licht JD; Keats JJ; Boise LH; Ebert BL; Bradner JE; Gray NS; Mitsiades CS
    Cell Rep; 2021 Jan; 34(1):108532. PubMed ID: 33406420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding PROTACtable genome universe of E3 ligases.
    Liu Y; Yang J; Wang T; Luo M; Chen Y; Chen C; Ronai Z; Zhou Y; Ruppin E; Han L
    Nat Commun; 2023 Oct; 14(1):6509. PubMed ID: 37845222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of Cereblon-Recruiting HaloPROTACs.
    Ody BK; Zhang J; Nelson SE; Xie Y; Liu R; Dodd CJ; Jacobs SE; Whitzel SL; Williams LA; Gozem S; Turlington M; Yin J
    Chembiochem; 2023 Nov; 24(21):e202300498. PubMed ID: 37625128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.
    Akuffo AA; Alontaga AY; Metcalf R; Beatty MS; Becker A; McDaniel JM; Hesterberg RS; Goodheart WE; Gunawan S; Ayaz M; Yang Y; Karim MR; Orobello ME; Daniel K; Guida W; Yoder JA; Rajadhyaksha AM; Schönbrunn E; Lawrence HR; Lawrence NJ; Epling-Burnette PK
    J Biol Chem; 2018 Apr; 293(16):6187-6200. PubMed ID: 29449372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A beginner's guide to current synthetic linker strategies towards VHL-recruiting PROTACs.
    Zografou-Barredo NA; Hallatt AJ; Goujon-Ricci J; Cano C
    Bioorg Med Chem; 2023 Jun; 88-89():117334. PubMed ID: 37224698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules.
    Hickey CM; Digianantonio KM; Zimmermann K; Harbin A; Quinn C; Patel A; Gareiss P; Chapman A; Tiberi B; Dobrodziej J; Corradi J; Cacace AM; Langley DR; Békés M
    Nat Struct Mol Biol; 2024 Feb; 31(2):311-322. PubMed ID: 38177675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
    Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
    J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.